Internal Medicine · New York, NY
NPI
1770555088
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
31 Washington Sq West
New York, NY, 10011
Phone (212) 475-8833
Groups this clinician bills Medicare through
Medicare paid, 2024
$115K
1,424 services
Medicare patients, 2024
401
Average age 75
Drug cost, 2024
$1.3M
2,958 prescriptions
Company payments, 2025
$202
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by William F Mandell was code 99214 (office e&m - established), 395 times for 213 patients. In total William F Mandell billed 1,424 services in 32 codes, and Medicare paid $115K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 395 | 213 | $100.74 | $40K |
| 99213 Office E&M - Established | Office | 270 | 175 | $61.99 | $17K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 122 | 122 | $142.73 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 98 | 80 | $13.71 | $1,344 |
| 91320 Vaccine Product | Office | 69 | 60 | $140.45 | $9,691 |
| 90480 Vaccine Administration | Office | 69 | 60 | $48.35 | $3,336 |
| 90653 Vaccine Product | Office | 68 | 68 | $81.82 | $5,564 |
| G0008 Administration of influenza virus vaccine | Office | 64 | 64 | $36.26 | $2,321 |
| 99232 Hospital E&M - Subsequent | Facility | 59 | 23 | $67.19 | $3,964 |
| 90471 Vaccine Administration | Office | 20 | 20 | $16.53 | $331 |
| 93000 Electrocardiogram | Office | 20 | 20 | $11.48 | $230 |
| 99222 Hospital E&M - Initial | Facility | 17 | 17 | $112.29 | $1,909 |
| 90677 Vaccine Product | Office | 16 | 16 | $290.36 | $4,646 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 15 | 15 | $20.95 | $314 |
| 99215 Office E&M - Established | Office | 13 | 12 | $155.83 | $2,026 |
By year: 2022 $122K for 1,298 services; 2023 $135K for 1,464 services; 2024 $115K for 1,424 services.
Medicare prescription drug claims, 2024
In 2024, the drug William F Mandell prescribed most often to Medicare patients was Amlodipine Besylate, with 196 prescriptions and refills. In total William F Mandell wrote 2,958 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 196 | 479 | 52 | $1,316 |
| Dovato Dolutegravir Sodium/Lamivudine | 136 | 150 | 15 | $453K |
| Atorvastatin Calcium Generic | 119 | 340 | 38 | $1,022 |
| Zolpidem Tartrate Generic | 117 | 117 | 24 | $1,615 |
| Rosuvastatin Calcium Generic | 116 | 290 | 31 | $1,422 |
| Tamsulosin Hcl Generic | 104 | 181 | 21 | $1,168 |
| Losartan Potassium Generic | 89 | 222 | 26 | $927 |
| Metoprolol Succinate Generic | 81 | 198 | 20 | $886 |
| Lisinopril Generic | 78 | 187 | 19 | $471 |
| Hydrochlorothiazide Generic | 77 | 159 | 14 | $461 |
| Levothyroxine Sodium Generic | 74 | 222 | 19 | $727 |
| Escitalopram Oxalate Generic | 72 | 118 | 15 | $777 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 62 | 68 | Under 11 | $271K |
| Simvastatin Generic | 52 | 139 | 13 | $706 |
| Valacyclovir Valacyclovir Hcl | 51 | 71 | 15 | $2,825 |
Brand drugs: - claims; generic drugs: 2,390 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid William F Mandell $202 ($202 in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbvie Inc. with $68.52.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.